KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nektar Therapeutics (NKTR) Consolidated Net Income: 2009-2024

Historic Consolidated Net Income for Nektar Therapeutics (NKTR) over the last 16 years, with Dec 2024 value amounting to -$119.0 million.

  • Nektar Therapeutics' Consolidated Net Income rose 5.58% to -$35.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$113.4 million, marking a year-over-year increase of 32.63%. This contributed to the annual value of -$119.0 million for FY2024, which is 56.90% up from last year.
  • Nektar Therapeutics' Consolidated Net Income amounted to -$119.0 million in FY2024, which was up 56.90% from -$276.1 million recorded in FY2023.
  • Nektar Therapeutics' 5-year Consolidated Net Income high stood at -$119.0 million for FY2024, and its period low was -$525.1 million during FY2021.
  • Over the past 3 years, Nektar Therapeutics' median Consolidated Net Income value was -$276.1 million (recorded in 2023), while the average stood at -$256.7 million.
  • As far as peak fluctuations go, Nektar Therapeutics' Consolidated Net Income dropped by 18.15% in 2021, and later soared by 56.90% in 2024.
  • Yearly analysis of 5 years shows Nektar Therapeutics' Consolidated Net Income stood at -$444.4 million in 2020, then declined by 18.15% to -$525.1 million in 2021, then climbed by 28.56% to -$375.1 million in 2022, then increased by 26.41% to -$276.1 million in 2023, then surged by 56.90% to -$119.0 million in 2024.